Single-injection intravitreal bevacizumab versus bevacizumab–triamcinolone for diabetic macular edema: a prospective comparative observational study evaluating efficacy, durability and intraocular pressure safety during 12 weeks of follow-up. SJ Ophthalmology Africa, [S. l.], v. 3, n. 3, p. 9, 2026. DOI: 10.51168/w9sfw022. Disponível em: https://ophthalmology.sjpublisher.org/index.php/SJOpht/article/view/64.. Acesso em: 27 aug. 2026.